Sports
Doer Biologics Completes Enrollment of the Phase 2 Clinical Study of DR10624 for Treatment of Severe Hypertriglyceridemia
Zhejiang Doer Biologics Co., Ltd.
HÄAGEN-DAZS CELEBRATES FIVE TRAILBLAZING WOMEN AS THE WINNERS OF THE ROSE PROJECT ARE REVEALED
Häagen-Dazs, General Mills
/C O R R E C T I O N -- Newmark Group, Inc./
Newmark Group, Inc.
Dongfeng powers a fuel-free journey from Wuhan to Harbin
Changjiang Daily
DouYu International Holdings Limited to Report Fourth Quarter and Full Year 2024 Financial Results on March 14, 2025
DouYu International Holdings Limited
